Overcoming poor bioavailability through amorphous solid dispersions

Industrial Pharmacy

Volumn , Issue 30, 2011, Pages 4-6

  Duarte, Iris ^a   Temtem, Márcio ^a   Gil, Marco ^a   Gaspar, Filipe ^a  

^a Particle Design Discipline of Hovione's R and D in Loures   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMORPHOUS SOLID DISPERSION; ARTICLE; DISPERSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; DRUG MARKETING; HIGH THROUGHPUT SCREENING; MOLECULAR MODEL; SPRAY DRYING;

EID: 84859031553     PISSN: 17414911     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (10)

1. Berkrot, B. (2010). Global pharmaceutical sales are expected to reach $1.1 trillion in 2014 as growth in emerging markets helps offset the impact of generic competition for many of the world's top selling drugs, according to a forecast by IMS Health. Reuters. Retrieved from www.reuters.com/article/2010/04/20/uspharmaceuticals- forecastidUSTRE63J35O20100420;
2. Owide, J. (2010). Why the smart money is on developing injectables. Informa UK Ltd. Retrieved from www.scrip100.com/drug-delivery;
3. Advanced Oral & Parenteral Drug Delivery Technologies: Players, Products & Prospects to 2015. Espicom Business Intelligence Ltd (2011). Retrieved from www.researchandmarkets.com/reports/1532036/advanced-oral-and- parenteral-drug-d elivery;
4. Water-Insoluble Drug Formulation (and references therein) 2nd Edition. Editor Liu, R.CRC Press, Taylor & Francis Group;
5. Curatolo, W. et al. (2009). Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu. Pharmaceutical Research, vol. 26, no.6, pp. 1419-1431;
6. Engers, D. et al. (2010). A solid-state approach to enable early development compounds: selection and animal biovavailability studies of an Itraconazole amorphous solid dispersion, Journal of Pharmaceutical Sciences, vol. 99, no.9, pp. 3901-3922;
7. Hancock B.C., Zografi G. (1997). Characteristics and Significance of the Amorphous State in Pharmaceutical Systems, Journal of Pharmaceutical Sciences, 86, 1-12;
8. Eudragit® Application Guidelines (2008). 10th revised edition. Evonik;
9. Bühler, V. (2007). Kollicoat® Grades. Functional Polymers for the pharmaceutical Industry. BASF;
10. Bühler, V. (2008). Kollidon®. Polyvinylpyrrolidone excipients for the pharmaceutical industry. BASF.